Historical Valuation
Precision BioSciences Inc (DTIL) is now in the Overvalued zone, suggesting that its current forward PS ratio of 6.36 is considered Overvalued compared with the five-year average of -2.44. The fair price of Precision BioSciences Inc (DTIL) is between 0.92 to 3.07 according to relative valuation methord. Compared to the current price of 4.03 USD , Precision BioSciences Inc is Overvalued By 31.09%.
Relative Value
Fair Zone
0.92-3.07
Current Price：4.03
31.09%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Precision BioSciences Inc (DTIL) has a current Price-to-Book (P/B) ratio of 2.98. Compared to its 3-year average P/B ratio of 1.78 , the current P/B ratio is approximately 67.18% higher. Relative to its 5-year average P/B ratio of 3.24, the current P/B ratio is about -8.05% higher. Precision BioSciences Inc (DTIL) has a Forward Free Cash Flow (FCF) yield of approximately -74.41%. Compared to its 3-year average FCF yield of -108.68%, the current FCF yield is approximately -31.53% lower. Relative to its 5-year average FCF yield of -75.58% , the current FCF yield is about -1.54% lower.
P/B
Median3y
1.78
Median5y
3.24
FCF Yield
Median3y
-108.68
Median5y
-75.58
Competitors Valuation Multiple
AI Analysis for DTIL
The average P/S ratio for DTIL competitors is 1.91, providing a benchmark for relative valuation. Precision BioSciences Inc Corp (DTIL.O) exhibits a P/S ratio of 6.36, which is 232.37% above the industry average. Given its robust revenue growth of -97.74%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for DTIL
1Y
3Y
5Y
Market capitalization of DTIL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DTIL in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DTIL currently overvalued or undervalued?
Precision BioSciences Inc (DTIL) is now in the Overvalued zone, suggesting that its current forward PS ratio of 6.36 is considered Overvalued compared with the five-year average of -2.44. The fair price of Precision BioSciences Inc (DTIL) is between 0.92 to 3.07 according to relative valuation methord. Compared to the current price of 4.03 USD , Precision BioSciences Inc is Overvalued By 31.09% .
What is Precision BioSciences Inc (DTIL) fair value?
DTIL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Precision BioSciences Inc (DTIL) is between 0.92 to 3.07 according to relative valuation methord.
How does DTIL's valuation metrics compare to the industry average?
The average P/S ratio for DTIL's competitors is 1.91, providing a benchmark for relative valuation. Precision BioSciences Inc Corp (DTIL) exhibits a P/S ratio of 6.36, which is 232.37% above the industry average. Given its robust revenue growth of -97.74%, this premium appears unsustainable.
What is the current P/B ratio for Precision BioSciences Inc (DTIL) as of Jan 09 2026?
As of Jan 09 2026, Precision BioSciences Inc (DTIL) has a P/B ratio of 2.98. This indicates that the market values DTIL at 2.98 times its book value.
What is the current FCF Yield for Precision BioSciences Inc (DTIL) as of Jan 09 2026?
As of Jan 09 2026, Precision BioSciences Inc (DTIL) has a FCF Yield of -74.41%. This means that for every dollar of Precision BioSciences Inc’s market capitalization, the company generates -74.41 cents in free cash flow.
What is the current Forward P/E ratio for Precision BioSciences Inc (DTIL) as of Jan 09 2026?
As of Jan 09 2026, Precision BioSciences Inc (DTIL) has a Forward P/E ratio of -1.32. This means the market is willing to pay $-1.32 for every dollar of Precision BioSciences Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Precision BioSciences Inc (DTIL) as of Jan 09 2026?
As of Jan 09 2026, Precision BioSciences Inc (DTIL) has a Forward P/S ratio of 6.36. This means the market is valuing DTIL at $6.36 for every dollar of expected revenue over the next 12 months.